Europe Polyacrylamide Market Size, Share & Industry Trends Analysis Report By Product (Anionic, Cationic, and Non-ionic), By Application (Water Treatment, Oil & Gas, Paper Making), By Country and Growth Forecast, 2023 - 2030
The Europe Polyacrylamide Market would witness market growth of 6.3% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 298.7 Kilo Tonnes, showcasing a growth of 5.2% (2019-2022).
Polyacrylamide is a versatile and widely used synthetic polymer with applications spanning various industries. This high-demand chemical compound's exceptional properties and adaptability have gained prominence. Polyacrylamide (PAM) is applied in diverse industries, making it a vital component in several processes. Its properties, which include high water solubility, absorbency, and the ability to form gels and films, make it suitable for various applications.
Moreover, polyacrylamide plays a crucial role in water and wastewater treatment. It is used as a flocculant to remove impurities from water sources, such as suspended solids and organic matter. This application is vital for ensuring access to clean and safe drinking water and treating industrial wastewater. In the oil and gas industry, polyacrylamide is employed in Enhanced Oil Recovery (EOR) techniques to increase oil recovery from reservoirs. It enhances the viscosity of water, facilitating better displacement of oil and improving extraction efficiency.
Additionally, many European countries have been investing in upgrading and expanding their wastewater treatment facilities to meet stringent water quality standards set by the European Union (EU) under the Urban Wastewater Treatment Directive. These projects involve improving the efficiency of treatment plants, reducing energy consumption, and enhancing the removal of contaminants from wastewater. In regions facing water scarcity, such as southern Spain and Cyprus, desalination projects have been implemented to produce freshwater from seawater or brackish water sources. These facilities provide an additional source of clean water for domestic and agricultural use.
Polyacrylamide is employed in sludge dewatering processes to improve the efficiency of mechanical dewatering methods like belt filter presses and centrifuges. It acts as a flocculant to increase the solid content of sludge, reducing the volume of sludge that needs to be disposed of. It is also applied in industrial wastewater treatment processes to treat effluent from various industries, including pulp and paper, mining, and food processing. It helps in the removal of pollutants, solids, and contaminants from industrial wastewater. Therefore, the demand for polyacrylamides will increase rapidly in the coming years.
The Germany market dominated the Europe Polyacrylamide Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $354.3 Million by 2030. The UK market is experiencing a CAGR of 5.4% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 7% during (2023 - 2030).
Based on Product, the market is segmented into Anionic, Cationic, and Non-ionic. Based on Application, the market is segmented into Water Treatment, Oil & Gas, Paper Making, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Anhui Jucheng Fine Chemicals Co., LTD, Ashland, Inc., BASF SE, Kemira Oyj, SNF Group, Black Rose Industries Ltd., Shandong Baomo Biochemical Co., Ltd., Xitao Polymer Co., Ltd., The Dow Chemical Company (Dow Corning Ltd.), and Solvay SA.
Scope of the Study
Market Segments covered in the Report:
By Product (Volume, Kilo Tonnes, USD Million, 2019-2030)
- Anionic
- Cationic
- Non-ionic
- Water Treatment
- Oil & Gas
- Paper Making
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Anhui Jucheng Fine Chemicals Co., LTD
- Ashland, Inc.
- BASF SE
- Kemira Oyj
- SNF Group
- Black Rose Industries Ltd.
- Shandong Baomo Biochemical Co., Ltd.
- Xitao Polymer Co., Ltd.
- The Dow Chemical Company (Dow Corning Ltd.)
- Solvay SA
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Pigmentation Disorder Treatment Market, by Type
- 1.4.2 Europe Pigmentation Disorder Treatment Market, by Treatment
- 1.4.3 Europe Pigmentation Disorder Treatment Market, by Distribution Channel
- 1.4.4 Europe Pigmentation Disorder Treatment Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter Five Forces Analysis
- Chapter 4. Europe Pigmentation Disorder Treatment Market, By Type
- 4.1 Europe Vitiligo Market, By Country
- 4.2 Europe Melasma Market, By Country
- 4.3 Europe Others Market, By Country
- Chapter 5. Europe Pigmentation Disorder Treatment Market, By Treatment
- 5.1 Europe Corticosteroids Market, By Country
- 5.2 Europe Calcineurin Inhibitor Market, By Country
- 5.3 Europe Others Market, By Country
- Chapter 6. Europe Pigmentation Disorder Treatment Market, By Distribution Channel
- 6.1 Europe Drug Store & Retail Pharmacies Market, By Country
- 6.2 Europe Hospital Pharmacies Market, By Country
- 6.3 Europe Online Pharmacies Market, By Country
- Chapter 7. Europe Pigmentation Disorder Treatment Market, By Country
- 7.1 Germany Pigmentation Disorder Treatment Market
- 7.1.1 Germany Pigmentation Disorder Treatment Market, By Type
- 7.1.2 Germany Pigmentation Disorder Treatment Market, By Treatment
- 7.1.3 Germany Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.2 UK Pigmentation Disorder Treatment Market
- 7.2.1 UK Pigmentation Disorder Treatment Market, By Type
- 7.2.2 UK Pigmentation Disorder Treatment Market, By Treatment
- 7.2.3 UK Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.3 France Pigmentation Disorder Treatment Market
- 7.3.1 France Pigmentation Disorder Treatment Market, By Type
- 7.3.2 France Pigmentation Disorder Treatment Market, By Treatment
- 7.3.3 France Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.4 Russia Pigmentation Disorder Treatment Market
- 7.4.1 Russia Pigmentation Disorder Treatment Market, By Type
- 7.4.2 Russia Pigmentation Disorder Treatment Market, By Treatment
- 7.4.3 Russia Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.5 Spain Pigmentation Disorder Treatment Market
- 7.5.1 Spain Pigmentation Disorder Treatment Market, By Type
- 7.5.2 Spain Pigmentation Disorder Treatment Market, By Treatment
- 7.5.3 Spain Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.6 Italy Pigmentation Disorder Treatment Market
- 7.6.1 Italy Pigmentation Disorder Treatment Market, By Type
- 7.6.2 Italy Pigmentation Disorder Treatment Market, By Treatment
- 7.6.3 Italy Pigmentation Disorder Treatment Market, By Distribution Channel
- 7.7 Rest of Europe Pigmentation Disorder Treatment Market
- 7.7.1 Rest of Europe Pigmentation Disorder Treatment Market, By Type
- 7.7.2 Rest of Europe Pigmentation Disorder Treatment Market, By Treatment
- 7.7.3 Rest of Europe Pigmentation Disorder Treatment Market, By Distribution Channel
- Chapter 8. Company Profiles
- 8.1 Bausch Health Companies Inc
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
- 8.2 Glenmark Pharmaceuticals Limited
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expenses
- 8.2.5 SWOT Analysis
- 8.3 Obagi Cosmeceuticals LLC
- 8.3.1 Company Overview
- 8.3.2 SWOT Analysis
- 8.4 AbbVie, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expense
- 8.5 Dermavant Sciences, Inc. (Roivant Sciences Ltd.)
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Research & Development Expenses
- 8.5.4 SWOT Analysis
- 8.6 Incyte Corporation
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Research & Development Expenses
- 8.6.3.1 Acquisition and Mergers:
- 8.6.3.2 Trials and Approvals:
- 8.6.4 SWOT Analysis
- 8.7 Dr. Reddy’s Laboratories Ltd.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
- 8.8 Galderma S.A.
- 8.8.1 Company Overview
- 8.9 Viatris, Inc. (Mylan N.V.)
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
- 8.10. Pfizer, Inc.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional & Segmental Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook